Skip to main content
. Author manuscript; available in PMC: 2014 Apr 17.
Published in final edited form as: Bioconjug Chem. 2013 Apr 2;24(4):658–668. doi: 10.1021/bc300632w

Table 2.

Cytotoxicity of drugs and drug conjugates in cancer cells

Drug formulations IC50 value (μM)* Enhancement factor
Etoposide 12.3 -
HA-ETO 6.3 1.9
CHA-ETO 3 4.2
Salinomycin 5.1 -
HA-SAL 3.2 1.6
CHA-SAL 0.9 5.4
Curcumin 19 -
HA-CUR 70 0.3
CHA-CUR 9 2.1
*

Cytotoxicity was measured after 72-h treatment. Enhancement factor shows the drug conjugate efficacy compared to free drug. CHA cytotoxicity (IC50) was > 5 mg/mL. The data are average of eight parallel measurements. Etoposide and salinomycin conjugates were tested in MDA-MB-231/F cells; curcumin conjugates were tested in MIA PaCa-2 cells.